Outsourced Pharma App Notes & Case Studies

  1. Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines 3/24/2025

    Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.

  2. How To Successfully Isolate Your T Cells 10/7/2024

    Explore the results of a study focusing on the early stages of the CAR T cell workflow, specifically the initial washing of leukapheresis followed by the isolation of T cells.

  3. Providing Packing And Blinding Solutions For An Innovative Drug Start-Up 9/13/2024

    Discover how a CDMO with integrated services enabled a botanical drug start-up to commence its Phase 1 clinical trial, paving the way for further advancement of its innovative botanical drug.

  4. Successful Site Transfer Of Tablet Production From Ex-US To Georgia Site 6/11/2025

    Learn how strategic U.S.-based manufacturing and supply chain diversification can reduce risk, lower costs, and enhance supply reliability for pharmaceutical products.

  5. Get Full Control Of Your T Cell Isolation 3/25/2024

    This study demonstrates the automated magnetic isolation of CD4/CD8+ cells from fresh or frozen leukapheresis using a functionally closed cell processing system paired with a modular application.

  6. Achieving Faster Timelines And Cost Savings Through Digital Validation 2/11/2025

    Examine how the Project Ready program was leveraged to streamline validation processes for a CDMO, resulting in a 25% reduction in budget and faster project completion.

  7. Nuances Of Sample Preparation For UHPLC Testing In Early Phase Stability Programs 2/13/2025

    In early-phase drug development, precise sample preparation for UHPLC testing is crucial to ensure accurate and reliable stability data.

  8. Understanding Technology Transfer In Pharmaceutical Contract Manufacturing 10/16/2024

    Technology transfer is a crucial process in the pharmaceutical industry, ensuring drugs developed in labs can be manufactured consistently at scale.

  9. Strategic Space Management 8/23/2024

    A pharmaceutical company facing storage space issues decided to outsource its reference samples to Q1 Scientific, a stability storage service provider, resulting in cost savings.

  10. Modelling TPDs Utilizing Computational And Medicinal Chemistry Approaches 5/16/2025

    Through a carefully executed strategy, see how we identified novel degrader molecules with the right physicochemical properties to achieve robust degradation of the target Protein of Interest (POI).